JAMES C. MOMTAZEE - 17 Jul 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for James C. Momtazee
Issuer symbol
ROIV
Transactions as of
17 Jul 2025
Net transactions value
-$2,808
Form type
4
Filing time
21 Jul 2025, 21:00:21 UTC
Previous filing
24 Jun 2025
Next filing
12 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MOMTAZEE JAMES C Director C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM By: /s/ Jo Chen, as Attorney-in-Fact for James C. Momtazee 21 Jul 2025 0001209181

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +1,201 +1.3% $0.000000 96,911 17 Jul 2025 Direct F1
transaction ROIV Common Shares Tax liability $2,808 -241 -0.25% $11.65 96,670 17 Jul 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
F2 Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.